Ricardo Zayas - Jan 25, 2023 Form 3 Insider Report for Catalent, Inc. (CTLT)

Role
SVP, Operations, Biologics NA
Signature
/s/ Amy Fallone, attorney-in-fact
Stock symbol
CTLT
Transactions as of
Jan 25, 2023
Transactions value $
$0
Form type
3
Date filed
2/6/2023, 06:20 PM
Next filing
Aug 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTLT Common Stock 1.79K Jan 25, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTLT Options to purchase Common Stock Jan 25, 2023 Common Stock 6.68K $52.59 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units, each representing the right to receive one share of the Issuer's common stock as of the date of vesting, which is scheduled to occur on January 23, 2026.
F2 Options are scheduled to vest and become exercisable in four equal annual installments beginning on January 23, 2024.

Remarks:

EXHIBIT LIST: EX-24 Ricardo Zayas POA